Home
Conditions
Multiple Myeloma (MM)

Clinical trial condition

Multiple Myeloma (MM)

Explore clinical trials studying Multiple Myeloma (MM). Study availability and eligibility vary by location and protocol.

61 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma (MM) trial results

Not yet recruiting

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

NCT07181239

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not yet recruiting

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT07107204

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
Locations: Not specified

View Trial Details

Not yet recruiting

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

NCT07113496

Conditions: B-cell Acute Lymphoblastic Leukemia (B-ALL), Blood Protein Disorders, Burkitt Lymphoma, +34 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not yet recruiting

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

NCT07034755

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), Blood Protein Disorders, Cardiovascular Diseases, +15 more
Locations: The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Not yet recruiting

Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

NCT06720207

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Clinical Trial Evaluating the Safety Tolerability, Radiation Absorption Dose, Distribution, PET Imaging and Histological Expression of 68Ga-NOTA-SCH001 in Patients With Multiple Myeloma

NCT06925958

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Multiple Myeloma is a Hematologic Malignancy Characterized by the Accumulation of Malignant Plasma Cells in the Bone Marrow. Despite Advances in Treatment, Many Patients Experience Disease Relapse. Bispecific Antibodies Offer an Innovative Therapeutic Approach, But Approximately 30%-40% of Patients

NCT06888856

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer

NCT06817759

Conditions: Anxiety Disorders, Blood Cancer, Blood Protein Disorders, +24 more
Locations: Centre de Recherche de l'Hôpital Maissonneuve-Rosemont Montreal, Quebec, Canada

View Trial Details

Active, not recruiting

Mobile App Education Based on Orem's Self-Care Model in Multiple Myeloma Patients

NCT07088783

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Dokuz Izmir, Turkey (Türkiye)

View Trial Details

Completed

Rehabilitation Management for Patients With Multiple Myeloma

NCT06838065

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: AUSL-IRCCS of Reggio EmiliaOperational Unit of Physical Medicine and Rehabilitation AUSL - IRCCS Reggio Emilia, Reggio Emilia, Emilia Romagna 42123 Reggio Emilia, Italy

View Trial Details

Multiple Myeloma (MM)

Multiple Myeloma (MM) trial results

Related conditions